Affiliation:
1. University of Sulaimani
Abstract
Abstract
Background: Since breast cancer (BC) has the best chance of being effectively treated when it is tiny and has not spread, encouraging early disease detection remains a fundamental goal in improving prognosis.
Objective: To better understand what factors contribute to a late presentation of BC, how this affects disease progression, and to assess awareness of BC warning signs.
Patients and methods: Data was collected at the Breast Diseases Treatment Clinic, Shar Teaching Hospital, Sulaimaniyah, Iraq Sulaimani, from January 2017 to December 2021 on 429 patients. A questionnaire was distributed to women about their demographics, health, and general awareness of the disease. The patient delay was calculated by collecting information on when they initially began experiencing symptoms and when they saw a doctor. We also gleaned information about the tumour's clinicopathological features from the patient's medical records.
Results: The participants' age ranged from 24 to 85 years, with a mean of 49.6±11. Most women were middle-aged (53.8%), from urban areas (80.2%), illiterate (41.7%), married (86.5%), housewives (79.0%), given birth to>4 children (34%), practised breastfeeding (78.8%), and no smokers (91.4%). Regarding patients' health behaviours associated with delay in breast cancer presentation, there were highly significant correlations between early and late screenings (P<0.001). Concerning the patient’s awareness of breast cancer symptoms, there were highly significant correlations between early and late screenings (P<0.001). In addition, the late presentation was strongly correlated with bilateral BC, lymph node involvement, inflammatory breast carcinoma, grade III of BC, and T4 status.
Conclusions: Our findings shed light on possible causes of late presentation and identified those at risk of delayed consultation. Our communities need to be educated about BC, and encouraging them for early detection, decreases the incidence of advanced BC.
Publisher
Research Square Platform LLC
Reference39 articles.
1. Gibberd R. Globocan 1: cancer incidence and mortality worldwide., Ferlay J, Parkin DM, Pisani P. IARC Press, Lyon, 1999. Wiley Online Library; 2000.
2. Assessment of breast cancer risk among Iraqi women in 2019;Hashim HT;BMC Womens Health,2021
3. Burdens of breast cancer upon women’s psychological health at Oncology Hospitals in Baghdad City;Abdalzahra RN;Iraqi J Public Health,2017
4. Breast cancer in Kurdish women of northern Iraq: incidence, clinical stage, and case-control analysis of parity and family risk;Majid RA;BMC Womens Health,2009
5. Westernizing” women's risks? Breast cancer in lower-income countries;Porter P;N Engl J Med,2008